<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
<url>
<loc>https://www.fibrosis-inflammation.com/en</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/cro-partners</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/resources</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/dashboard</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/compare</loc>
<lastmod>2026-03-29T13:34:28.613Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_fibrosis_assessment</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_fibrosis_assessment" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_fibrosis_assessment" />
<lastmod>2026-03-26T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_prophylactic_vs_therapeutic</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_prophylactic_vs_therapeutic" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_prophylactic_vs_therapeutic" />
<lastmod>2026-03-05T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_pf_micro_sprayer</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_pf_micro_sprayer" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_pf_micro_sprayer" />
<lastmod>2026-03-05T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_mash_models_evolution</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_mash_models_evolution" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_mash_models_evolution" />
<lastmod>2026-02-12T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_biopsy_confirmed_design</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_biopsy_confirmed_design" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_biopsy_confirmed_design" />
<lastmod>2026-02-12T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_ssc_clinical_relevance</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_ssc_clinical_relevance" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_ssc_clinical_relevance" />
<lastmod>2026-02-11T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_scleroderma_models</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_scleroderma_models" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_scleroderma_models" />
<lastmod>2026-02-11T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_exosomes_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_exosomes_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_exosomes_fibrosis" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/edu_cardiac_fibrosis_hfpef</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_cardiac_fibrosis_hfpef" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_cardiac_fibrosis_hfpef" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_senolytics</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_senolytics" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_senolytics" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_integrin_inhibitors</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_integrin_inhibitors" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_integrin_inhibitors" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_cardiac_fibrosis_hfpef</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_cardiac_fibrosis_hfpef" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_cardiac_fibrosis_hfpef" />
<lastmod>2025-12-29T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_study_rescue_strategy</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_study_rescue_strategy" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_study_rescue_strategy" />
<lastmod>2025-12-27T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_non_invasive_biomarkers</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_non_invasive_biomarkers" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_non_invasive_biomarkers" />
<lastmod>2025-12-26T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_organ_on_chip_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_organ_on_chip_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_organ_on_chip_fibrosis" />
<lastmod>2025-12-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/biz_mash_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_mash_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_mash_landscape_2025" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/biz_ipf_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_ipf_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_ipf_landscape_2025" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/biz_cro_outsourcing_guide</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_cro_outsourcing_guide" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_cro_outsourcing_guide" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_ibd_models</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_ibd_models" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_ibd_models" />
<lastmod>2025-12-22T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_mash_comprehensive_analysis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_mash_comprehensive_analysis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_mash_comprehensive_analysis" />
<lastmod>2025-12-22T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_ipf_treatment_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_ipf_treatment_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_treatment_landscape_2025" />
<lastmod>2025-12-21T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/tech_pulmonary_fibrosis_model</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_pulmonary_fibrosis_model" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_pulmonary_fibrosis_model" />
<lastmod>2025-12-20T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_ipf_clinical_trials</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_ipf_clinical_trials" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_clinical_trials" />
<lastmod>2025-12-10T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_mash_future</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_mash_future" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_mash_future" />
<lastmod>2025-12-09T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_semaglutide_mash</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_semaglutide_mash" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_semaglutide_mash" />
<lastmod>2025-12-08T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_resmetirom</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_resmetirom" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_resmetirom" />
<lastmod>2025-12-07T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/pathway_wnt_bcatenin</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/pathway_wnt_bcatenin" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/pathway_wnt_bcatenin" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/edu_inflammation_fibrosis_link</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_inflammation_fibrosis_link" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation_fibrosis_link" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/edu_inflammation</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_inflammation" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/edu_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_fibrosis" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/edu_fibroblasts</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_fibroblasts" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_fibroblasts" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/drug_antifibrotic</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_antifibrotic" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_antifibrotic" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/insights/biomarker_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biomarker_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biomarker_fibrosis" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/tac-heart-model</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/jak2-myelofibrosis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/isoproterenol-heart-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/dss-colitis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/folic-acid-nephropathy</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/bleomycin-skin-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/adjuvant-induced-arthritis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/stz-diabetic-nephropathy</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/ccl4-liver-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/mash-diet-induced</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/bleomycin-pulmonary-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/models/uuo-mouse-model</loc>
<lastmod>2026-03-29T13:34:28.654Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/abituzumab</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/fresolimumab</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/tanzisertib</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/zinpentraxin-alfa</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/gb0139</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/stm-434</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/pbi-4050</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/bexotegrast</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/pamrevlumab</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/resmetirom</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/nerandomilast</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/pirfenidone</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/nintedanib</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/semaglutide</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/tirzepatide</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/survodutide</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/efruxifermin</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/lanifibranor</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/pegozafermin</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/denifanstat</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/retatrutide</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/pemvidutide</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/orforglipron</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/en/drugs/vk2809</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/cro-partners</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/resources</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/dashboard</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/compare</loc>
<lastmod>2026-03-29T13:34:28.663Z</lastmod>
<changefreq>weekly</changefreq>
<priority>0.8</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_fibrosis_assessment</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_fibrosis_assessment" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_fibrosis_assessment" />
<lastmod>2026-03-26T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_prophylactic_vs_therapeutic</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_prophylactic_vs_therapeutic" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_prophylactic_vs_therapeutic" />
<lastmod>2026-03-05T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_pf_micro_sprayer</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_pf_micro_sprayer" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_pf_micro_sprayer" />
<lastmod>2026-03-05T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_mash_models_evolution</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_mash_models_evolution" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_mash_models_evolution" />
<lastmod>2026-02-12T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_biopsy_confirmed_design</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_biopsy_confirmed_design" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_biopsy_confirmed_design" />
<lastmod>2026-02-12T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_ssc_clinical_relevance</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_ssc_clinical_relevance" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_ssc_clinical_relevance" />
<lastmod>2026-02-11T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_scleroderma_models</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_scleroderma_models" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_scleroderma_models" />
<lastmod>2026-02-11T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_exosomes_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_exosomes_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_exosomes_fibrosis" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/edu_cardiac_fibrosis_hfpef</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_cardiac_fibrosis_hfpef" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_cardiac_fibrosis_hfpef" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_senolytics</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_senolytics" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_senolytics" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_integrin_inhibitors</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_integrin_inhibitors" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_integrin_inhibitors" />
<lastmod>2026-01-01T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_cardiac_fibrosis_hfpef</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_cardiac_fibrosis_hfpef" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_cardiac_fibrosis_hfpef" />
<lastmod>2025-12-29T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_study_rescue_strategy</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_study_rescue_strategy" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_study_rescue_strategy" />
<lastmod>2025-12-27T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_non_invasive_biomarkers</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_non_invasive_biomarkers" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_non_invasive_biomarkers" />
<lastmod>2025-12-26T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_organ_on_chip_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_organ_on_chip_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_organ_on_chip_fibrosis" />
<lastmod>2025-12-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/biz_mash_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_mash_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_mash_landscape_2025" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/biz_ipf_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_ipf_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_ipf_landscape_2025" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/biz_cro_outsourcing_guide</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biz_cro_outsourcing_guide" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biz_cro_outsourcing_guide" />
<lastmod>2025-12-23T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_ibd_models</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_ibd_models" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_ibd_models" />
<lastmod>2025-12-22T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_mash_comprehensive_analysis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_mash_comprehensive_analysis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_mash_comprehensive_analysis" />
<lastmod>2025-12-22T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_treatment_landscape_2025</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_ipf_treatment_landscape_2025" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_treatment_landscape_2025" />
<lastmod>2025-12-21T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/tech_pulmonary_fibrosis_model</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/tech_pulmonary_fibrosis_model" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/tech_pulmonary_fibrosis_model" />
<lastmod>2025-12-20T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_clinical_trials</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_ipf_clinical_trials" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_ipf_clinical_trials" />
<lastmod>2025-12-10T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_mash_future</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_mash_future" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_mash_future" />
<lastmod>2025-12-09T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_semaglutide_mash</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_semaglutide_mash" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_semaglutide_mash" />
<lastmod>2025-12-08T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_resmetirom</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_resmetirom" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_resmetirom" />
<lastmod>2025-12-07T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/pathway_wnt_bcatenin</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/pathway_wnt_bcatenin" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/pathway_wnt_bcatenin" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation_fibrosis_link</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_inflammation_fibrosis_link" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation_fibrosis_link" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_inflammation" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_inflammation" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/edu_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_fibrosis" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/edu_fibroblasts</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/edu_fibroblasts" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/edu_fibroblasts" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/drug_antifibrotic</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/drug_antifibrotic" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/drug_antifibrotic" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/insights/biomarker_fibrosis</loc>
<xhtml:link rel="alternate" hreflang="en" href="https://www.fibrosis-inflammation.com/en/insights/biomarker_fibrosis" />
<xhtml:link rel="alternate" hreflang="ja" href="https://www.fibrosis-inflammation.com/ja/insights/biomarker_fibrosis" />
<lastmod>2025-11-24T00:00:00.000Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.6</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/tac-heart-model</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/jak2-myelofibrosis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/isoproterenol-heart-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/dss-colitis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/folic-acid-nephropathy</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/bleomycin-skin-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/adjuvant-induced-arthritis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/stz-diabetic-nephropathy</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/ccl4-liver-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/mash-diet-induced</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/bleomycin-pulmonary-fibrosis</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/models/uuo-mouse-model</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/abituzumab</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/fresolimumab</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/tanzisertib</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/zinpentraxin-alfa</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/gb0139</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/stm-434</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/pbi-4050</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/bexotegrast</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/pamrevlumab</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/resmetirom</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/nerandomilast</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/pirfenidone</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/nintedanib</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/semaglutide</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/tirzepatide</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/survodutide</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/efruxifermin</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/lanifibranor</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/pegozafermin</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/denifanstat</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/retatrutide</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/pemvidutide</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/orforglipron</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
<url>
<loc>https://www.fibrosis-inflammation.com/ja/drugs/vk2809</loc>
<lastmod>2026-03-29T13:34:28.684Z</lastmod>
<changefreq>monthly</changefreq>
<priority>0.7</priority>
</url>
</urlset>
